Overview

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis

Status:
Enrolling by invitation

Trial end date:
2021-04-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of Adipose derived Mesenchymal Stem Cells (AD-MSCs) plus Calpocitriol Ointment with moderate to severe psoriasis. Any adverse events related to AD-MSCs infusion will be monitored.The primary outcome is the reduction rate of PASI(Psoriasis Area and Severity Index) and treatment response will be computed from PASI before and after treatment.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Guangdong Provincial Hospital of Traditional Chinese Medicine

Treatments:

Calcipotriene